JPH09503211A - 抗炎症薬としてのパーフルオロカーボン類 - Google Patents
抗炎症薬としてのパーフルオロカーボン類Info
- Publication number
- JPH09503211A JPH09503211A JP7510469A JP51046995A JPH09503211A JP H09503211 A JPH09503211 A JP H09503211A JP 7510469 A JP7510469 A JP 7510469A JP 51046995 A JP51046995 A JP 51046995A JP H09503211 A JPH09503211 A JP H09503211A
- Authority
- JP
- Japan
- Prior art keywords
- fluorocarbon
- liquid
- tissue
- inflammation
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.処置を必要とする患者の肺組織に炎症減少有効量のフルオロカーボン気体ま たはアエロゾルを接触させる段階を含んでなる、前記組織中での炎症反応を減少 させる方法。 2.前記組織が粘膜上皮を含む、請求の範囲第1項記載の方法。 3.前記組織が胃腸組織である、請求の範囲第2項記載の方法。 4.前記フルオロカーボンが液体または気体状フルオロカーボン類の混合物であ る、請求の範囲第1項記載の方法。 5.前記組織が肺組織である、請求の範囲第2項記載の方法。 6.前記炎症が成人呼吸窮迫症候群に伴うものである、請求の範囲第5項記載の 方法。 7.前記炎症が幼児呼吸窮迫症候群に伴うものである、請求の範囲第5項記載の 方法。 8.前記フルオロカーボンが気体の形状で投与される、請求の範囲第5項記載の 方法。 9.前記気体状フルオロカーボンが呼吸ガスと混合される、請求の範囲第8項記 載の方法。 10.前記フルオロカーボンが気体中に懸濁された小滴の形状で投与される、請 求の範囲第5項記載の方法。 11.前記フルオロカーボンが肺の中に酸素化された液体の形状で投与される、 請求の範囲第5項記載の方法。 12.前記フルオロカーボンが肺の中に液体の形状で投与され、そして該投与後 、前記フルオロカーボンが依然として肺の中にある間に患者が酸素化された気体 を呼吸する、請求の範囲第5項記載の方法。 13.前記液体フルオロカーボンが、該フルオロカーボン投与の前に酸素化され る、請求の範囲第12項記載の方法。 14.前記フルオロカーボンがエマルジョンの形状である、請求の範囲第1項記 載の方法。 15.前記フルオロカーボンの容量が肺の機能的残存量より実質的に少ない、請 求の範囲第1項記載の方法。 16.容器、 容器中の生物学的許容性のフルオロカーボン液体、および 患者による吸入用の前記フルオロカーボンの単位薬用量を噴霧化、アエロゾル化 または蒸発させるための前記容器に付随する手段 を含んでなる、患者の肺にフルオロカーボンを分配させる際に使用するための装 置。 17.さらに前記フルオロカーボンを患者の肺気道の中に注入するための手段を も含んでなる、請求の範囲第16項記載の装置。 18.組織を炎症減少有効量の液体フルオロカーボンと局所的に接触させる段階 を含んでなる、外皮または粘膜組織における炎症反応を減少させる方法。 19.患者に炎症減少有効量の液体フルオロカーボンを投与する段階を含んでな る、患者における全身的炎症性疾病を処置する方法。 20.前記投与段階が静脈内、筋肉内、動脈内および皮下投与よりなる群から選 択される、請求の範囲第19項記載の方法。 21.患者に炎症減少有効量の液体フルオロカーボンを経口的にまたは直腸に投 与する段階を含んでなる、患者における胃腸炎症を減少させる方法。 22.肺組織に炎症減少有効量のフルオロカーボン気体またはアエロゾルを接触 させる段階を含んでなる、前記組織中の炎症反応を減少させるための前記気体ま たはアエロゾルの使用。 23.前記炎症が成人呼吸窮迫症候群に伴うものである、請求の範囲第22項記 載の使用。 24.前記炎症が幼児呼吸窮迫症候群に伴うものである、請求の範囲第22項記 載の使用。 25.前記気体状フルオロカーボンが呼吸ガスと混合される、請求の範囲第22 項記載の使用。 26.前記フルオロカーボンが気体中に懸濁された小滴の形状で投与される、請 求の範囲第22項記載の使用。 27.前記フルオロカーボンの容量が肺の機能的残存量より実質的に少ない、請 求の範囲第22項記載の使用。 28.外皮または粘膜組織を炎症減少有効量の液体フルオロカーボンと局所的に 接触させる段階を含んでなる、前記組織における炎症反応を減少させるための前 記フルオロカーボンの使用。 29.炎症減少有効量のフルオロカーボンを投与する段階を含んでなる、全身的 炎症性疾病を処置するためのフルオロカーボン液体またはエマルジョンの使用。 30.炎症減少有効量のフルオロカーボンを経口的にまたは直腸に投与すること を含んでなる、胃腸炎症を処置するためのフルオロカーボン液体またはエマルジ ョンの使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/128,811 | 1993-09-29 | ||
US08/128,811 US5470885A (en) | 1993-09-29 | 1993-09-29 | Fluorocarbons as anti-inflammatory agents |
PCT/US1994/011092 WO1995008985A1 (en) | 1993-09-29 | 1994-09-29 | Perfluorocarbons as anti-inflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09503211A true JPH09503211A (ja) | 1997-03-31 |
Family
ID=22437089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7510469A Ceased JPH09503211A (ja) | 1993-09-29 | 1994-09-29 | 抗炎症薬としてのパーフルオロカーボン類 |
Country Status (8)
Country | Link |
---|---|
US (2) | US5470885A (ja) |
EP (1) | EP0738142B1 (ja) |
JP (1) | JPH09503211A (ja) |
AT (1) | ATE435646T1 (ja) |
AU (1) | AU691837B2 (ja) |
CA (1) | CA2172601A1 (ja) |
DE (1) | DE69435215D1 (ja) |
WO (1) | WO1995008985A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011148640A1 (ja) * | 2010-05-27 | 2011-12-01 | 株式会社 資生堂 | 血流促進剤および外用剤 |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1927192A (en) * | 1991-05-03 | 1992-12-21 | University Of Pittsburgh | Partial liquid breathing of fluorocarbons |
US5470885A (en) * | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
US5861175A (en) * | 1996-03-15 | 1999-01-19 | Alliance Pharmaceutical Corp. | Use of fluorocarbons for diagnosis and treatment of articular disorders |
WO1998016210A1 (en) * | 1996-10-15 | 1998-04-23 | Sonus Pharmaceuticals, Inc. | Fluorocarbon-containing agents for pulmonary lavage and drug delivery |
SE507617C2 (sv) * | 1996-12-20 | 1998-06-29 | Siemens Elema Ab | Anordning avsedd att användas vid ett behandlingssystem för respiratorvård med vätska |
US20060025348A1 (en) * | 1997-05-28 | 2006-02-02 | Pilon Aprile L | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
US6255281B1 (en) * | 1997-05-28 | 2001-07-03 | Claragen, Inc. And U.S. Government | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
US20060281681A1 (en) * | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6946117B1 (en) | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
US6433040B1 (en) | 1997-09-29 | 2002-08-13 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6309623B1 (en) | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
DE19823606C2 (de) * | 1998-05-27 | 2002-02-28 | Draeger Medical Ag | Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung |
US6894079B1 (en) | 1998-12-01 | 2005-05-17 | Alexandre T. Rotta | Method for reducing free-radical induced injury |
ES2160534B1 (es) * | 1999-12-30 | 2002-04-16 | Vita Invest Sa | Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo. |
US7442388B2 (en) | 2000-05-10 | 2008-10-28 | Weers Jeffry G | Phospholipid-based powders for drug delivery |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US6235796B1 (en) * | 2000-06-26 | 2001-05-22 | Sarfaraz K. Niazi | Use of fluorocarbons for the prevention of surgical adhesions |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
US6899890B2 (en) * | 2002-03-20 | 2005-05-31 | Kv Pharmaceutical Company | Bioadhesive drug delivery system |
JP4079257B2 (ja) * | 2002-10-01 | 2008-04-23 | 株式会社リコー | 静電荷像現像用トナー |
US20050118108A1 (en) * | 2003-11-28 | 2005-06-02 | Cowan Ada S. | Pulmonary delivery of a liquid medicament aerosol |
EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
US7566743B2 (en) * | 2005-11-18 | 2009-07-28 | Mark Glazman | System and method for medical treatment |
AU2006329199B8 (en) * | 2005-12-21 | 2014-01-09 | Solaeromed Inc. | Treatment of respiratory diseases |
WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
BRPI0911945A2 (pt) | 2008-05-13 | 2015-10-13 | Clarassance Inc | cc10 humana recombinante e suas composições para uso no tratamento de rinite nasal |
DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
US9168285B2 (en) | 2009-10-15 | 2015-10-27 | Therabron Therapeutics, Inc. | Recombinant human CC10 protein for treatment of influenza and ebola |
CN102834115B (zh) | 2009-10-15 | 2015-01-14 | 克拉莱森公司 | 用于治疗流感的重组人cc10蛋白 |
EP2587917A4 (en) * | 2010-07-01 | 2015-05-06 | Mtm Res Llc | THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
WO2023039605A1 (en) * | 2021-09-13 | 2023-03-16 | The Board Of Regents Of The University Of Texas System | Systemic injection of superheated perfluorocarbon emulsion to improve ventilation and reduce ventilator-induced lung injury |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4044121A (en) * | 1976-03-11 | 1977-08-23 | Minnesota Mining And Manufacturing Company | Hair spray containing fluorocarbon compounds as additives |
US4680173A (en) * | 1977-04-28 | 1987-07-14 | Norman D. Burger | Aerosol dispensing system |
US4490351A (en) * | 1982-03-15 | 1984-12-25 | Children's Hospital Medical Center | Methods of treating disorders of an eye with liquid perfluorocarbons |
US4543202A (en) * | 1984-03-23 | 1985-09-24 | E. I. Du Pont De Nemours And Company | Aerosol propellant compositions |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US4865836A (en) * | 1986-01-14 | 1989-09-12 | Fluoromed Pharmaceutical, Inc. | Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport |
US4927623A (en) * | 1986-01-14 | 1990-05-22 | Alliance Pharmaceutical Corp. | Dissolution of gas in a fluorocarbon liquid |
US4987154A (en) * | 1986-01-14 | 1991-01-22 | Alliance Pharmaceutical Corp. | Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use |
US5284645A (en) * | 1987-08-05 | 1994-02-08 | Alliance Pharmaceutical Corp. | Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems |
AU2807689A (en) * | 1986-09-19 | 1989-03-01 | Chemex Pharmaceuticals Inc. | Method for the treatment of body tissues and the administration of drugs thereto |
US4897262A (en) * | 1988-03-22 | 1990-01-30 | Playtex Jhirmack, Inc. | Non-aerosol hair spray composition |
US5028428A (en) * | 1988-08-09 | 1991-07-02 | Estee Lauder Inc. | Anti-irritant and desensitizing compositions and methods of their use |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5213570A (en) * | 1990-12-14 | 1993-05-25 | Mallinckrodt Medical, Inc. | System and method for oxygenation of the pericardium |
AU666852B2 (en) * | 1991-05-01 | 1996-02-29 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | A method for treating infectious respiratory diseases |
US5437272A (en) * | 1991-05-01 | 1995-08-01 | Alliance Pharmaceutical Corp. | Perfluorocarbon associated gas exchange |
AU1927192A (en) * | 1991-05-03 | 1992-12-21 | University Of Pittsburgh | Partial liquid breathing of fluorocarbons |
US5470885A (en) * | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
-
1993
- 1993-09-29 US US08/128,811 patent/US5470885A/en not_active Expired - Lifetime
-
1994
- 1994-09-29 AT AT94929390T patent/ATE435646T1/de not_active IP Right Cessation
- 1994-09-29 AU AU78469/94A patent/AU691837B2/en not_active Ceased
- 1994-09-29 JP JP7510469A patent/JPH09503211A/ja not_active Ceased
- 1994-09-29 CA CA002172601A patent/CA2172601A1/en not_active Abandoned
- 1994-09-29 DE DE69435215T patent/DE69435215D1/de not_active Expired - Fee Related
- 1994-09-29 WO PCT/US1994/011092 patent/WO1995008985A1/en active Application Filing
- 1994-09-29 EP EP94929390A patent/EP0738142B1/en not_active Expired - Lifetime
-
1995
- 1995-11-22 US US08/562,130 patent/US5733939A/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011148640A1 (ja) * | 2010-05-27 | 2011-12-01 | 株式会社 資生堂 | 血流促進剤および外用剤 |
Also Published As
Publication number | Publication date |
---|---|
EP0738142B1 (en) | 2009-07-08 |
CA2172601A1 (en) | 1995-04-06 |
EP0738142A1 (en) | 1996-10-23 |
DE69435215D1 (de) | 2009-08-20 |
AU691837B2 (en) | 1998-05-28 |
AU7846994A (en) | 1995-04-18 |
EP0738142A4 (en) | 1997-07-16 |
ATE435646T1 (de) | 2009-07-15 |
US5470885A (en) | 1995-11-28 |
US5733939A (en) | 1998-03-31 |
WO1995008985A1 (en) | 1995-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09503211A (ja) | 抗炎症薬としてのパーフルオロカーボン類 | |
JP2607021B2 (ja) | フルオロカーボンの部分液体呼吸 | |
Knight et al. | Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis | |
EP0612256B1 (en) | Apparatus for partial liquid ventilation using fluorocarbons | |
US5824703A (en) | Method of assisting normal breathing in a mammal having a lung disorder | |
JP5065047B2 (ja) | 肺表面活性物質の配合物 | |
PT2110126E (pt) | Utilização inalativa e instilativa de alcanos semifluorados como veículos de substância activa na região intrapulmonar | |
JPS634812B2 (ja) | ||
CA2190180C (en) | Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders | |
US20030039615A1 (en) | Method for treating bronchial constriction and bronchospasm | |
Brilli et al. | Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension | |
Kelly et al. | Randomised comparison of partial liquid ventilation, nebulised perfluorocarbon, porcine surfactant, artificial surfactant, and combined treatments on oxygenation, lung mechanics, and survival in rabbits after saline lung lavage | |
AU718120B2 (en) | Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir | |
Whittet et al. | Plasma lignocaine levels during paediatric endoscopy of the upper respiratory tract: Relationship with mueosal moistness | |
Cui et al. | Aerosolized surfactant and dextran for experimental acute respiratory distress syndrome caused by acidified milk in rats | |
Jendle et al. | Delivery and retention of an insulin aerosol produced by a new jet nebulizer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041012 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050107 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050221 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20050523 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050628 |